Market Tracker

12/09 5:16pm ET

Cleveland Biolabs Inc (NASDAQ:CBLI)

1.61
Delayed Data
As of Dec 09
 +0.01 / +0.63%
Today’s Change
1.45
Today|||52-Week Range
4.08
-53.87%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close1.60
Today’s open1.65
Day’s range1.60 - 1.68
Volume12,218
Average volume (3 months)39,444
Market cap$17.7M
Dividend yield--
Data as of 3:52pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-398.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-26.84%
P/E ratio161.0
Price/Sales9.10
Price/Book1.76

Competitors

 Today’s
change
Today’s
% change
BLPHBellerophon Therapeu...+0.05+10.23%
ONTXOnconova Therapeutic...-0.15-5.66%
CYCCCyclacel Pharmaceuti...-0.12-2.91%
EYEGEyeGate Pharmaceutic...+0.11+6.83%
Data as of 4:00pm ET, 12/09/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$2.7M
Annual profit (last year)-$12.6M
Net profit margin-466.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Yakov Kogan
President &
Chief Medical Officer
Langdon L. Miller
Corporate headquarters
Buffalo, New York

Forecasts